Analysis of DCE-MRI for Early Prediction of Breast Cancer Therapy Response

Positive response to neoadjuvant chemotherapy (NACT) has been correlated to better long-term outcomes in breast cancer treatment. Early prediction of response to NACT can help modify the regimen for non-responding patients, sparing them of potential toxicities of ineffective therapies. It has been observed that tumor functions such as vascularization and vascular permeability change even before noticeable changes occur in the tumor size in response to the treatment. Therefore, it is essential to have reliable imaging based features to measure these changes. Texture analysis on parametric maps from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has shown to be a good predictor of breast cancer response to NACT at an early stage. But hand crafted texture features might not be able to capture the rich spatio-temporal information in the parametric maps. In this work, we studied the ability of convolutional neural networks in predicting the response to NACT at an early stage.

[1]  S. Fedewa,et al.  Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening , 2017, CA: a cancer journal for clinicians.

[2]  Z. Werb,et al.  Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.

[3]  Abhishek Chatterjee,et al.  Neoadjuvant therapy for treatment of breast cancer: the way forward, or simply a convenient option for patients? , 2017, Gland surgery.

[4]  Bilwaj Gaonkar,et al.  Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response1 , 2015, Translational oncology.

[5]  Wei Huang,et al.  Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI1 , 2016, Translational oncology.

[6]  Woo Kyung Moon,et al.  Early Prediction of Response to Neoadjuvant Chemotherapy Using Parametric Response , 2015 .

[7]  A. Tutt,et al.  Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer , 2012, Annals of Surgical Oncology.

[8]  Subhransu Maji,et al.  Deep filter banks for texture recognition and segmentation , 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[9]  Thomas E. Yankeelov,et al.  The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge , 2016, Tomography.

[10]  Brandon Whitcher,et al.  Quantifying spatial heterogeneity in dynamic contrast‐enhanced MRI parameter maps , 2009, Magnetic resonance in medicine.

[11]  D. Bluemke,et al.  3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis. , 2011, AJR. American journal of roentgenology.

[12]  Wei Huang,et al.  DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response , 2017, Tomography.

[13]  James M Ford,et al.  Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer , 2013 .

[14]  Ron Kikinis,et al.  Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge. , 2014, Translational oncology.

[15]  L. Turnbull,et al.  Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy , 2005, Breast Cancer Research and Treatment.

[16]  Steinar Lundgren,et al.  Dynamic contrast‐enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer , 2014, NMR in biomedicine.

[17]  H. Huisman,et al.  Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging , 2012, European Radiology.

[18]  Jyh-Horng Chen,et al.  Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI. , 2004, Physics in medicine and biology.

[19]  Geon-Ho Jahng,et al.  True Progression versus Pseudoprogression in the Treatment of Glioblastomas: A Comparison Study of Normalized Cerebral Blood Volume and Apparent Diffusion Coefficient by Histogram Analysis , 2013, Korean journal of radiology.

[20]  Christos Hatzis,et al.  Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Luiz Eduardo Soares de Oliveira,et al.  Forest Species Recognition Using Deep Convolutional Neural Networks , 2014, 2014 22nd International Conference on Pattern Recognition.